Activin receptor type iia variants and methods of use thereof
US-2024050528-A1 · Feb 15, 2024 · US
US9279769B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9279769-B2 |
| Application number | US-201113992540-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2011 |
| Priority date | Dec 7, 2010 |
| Publication date | Mar 8, 2016 |
| Grant date | Mar 8, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides miniSOG proteins, polynucleotides, and methods of use. When expressed in a bacterial or mammalian cell, miniSOG proteins spontaneously incorporate flavin mononucleotide and produce fluorescence and singlet oxygen upon excitation. Uses include optical and electron microscope imaging, in vivo imaging, detection and localization of protein-protein interactions, and photoablation.
Opening claim text (preview).
What is claimed is: 1. An isolated polynucleotide encoding a miniSOG polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2. 2. The isolated polynucleotide of claim 1 , wherein the miniSOG comprises an amino acid sequence of SEQ ID NO:1. 3. The isolated polynucleotide of claim 1 , wherein the miniSOG polypeptide consists of 106 amino acids. 4. The isolated polynucleotide of claim 1 , wherein the miniSOG polypeptide has a singlet oxygen quantum yield of 0.47±0.05 or more when bound to a flavin mononucleotide. 5. The isolated polynucleotide of claim 1 , wherein the polynucleotide encoding the miniSOG polypeptide is codon optimized for expression in E. coli or a eukaryotic cell. 6. The isolated polynucleotide of claim 5 , wherein the eukaryotic cell is a mammalian cell. 7. The isolated polynucleotide of claim 5 , wherein the mammalian cell is a human cell. 8. A vector comprising the polynucleotide sequence of claim 1 . 9. A host cell comprising the vector of claim 8 . 10. A miniSOG polypeptide encoded by the polynucleotide of claim 1 . 11. A kit comprising the polynucleotide of claim 1 . 12. A fusion protein comprising a polypeptide encoded by the polynucleotide of claim 1 . 13. A method of expressing in a cell a fusion protein, the method comprising the step of: expressing in a cell a fusion protein comprising i)a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2 and ii) a protein if interest. 14. The isolated polynucleotide of claim 1 , wherein the miniSOG comprises an amino acid sequence of SEQ ID NO:2.
transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
by chemical synthesis · CPC title
Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase · CPC title
Fusion polypeptide · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.